VERBESSERUNG DER MSC-IMMUNMODULATORISCHEN EIGENSCHAFTEN DURCH TREPROSTINIL

Patent europeic · EP3534917 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3534917
Numer da la dumonda
EP17808627
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
23-10-2017
Publitgà
11-09-2019
Concedì
24-08-2022
Stritgà
25-05-2023
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 35/28 (2015.01)
C12N 5/0789 (2010.01)
A61P 9/00 (2006.01)
A61P 9/10 (2006.01)
A61P 11/00 (2006.01)
Prioritad
US 201662411950 P 24.10.2016
Dumonda PCT
PCT/US2017/057863 23.10.2017
Publicaziun PCT
WO2018/080990 03.05.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-07-2023

    Midada

    Published in Swissreg on 05.07.2023

  2. 25-05-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.05.2023

  3. 24-08-2022

    Concedì

    Published in Swissreg on 24.08.2022

Partidas

Inventur

HOGAN, Sarah

Raleigh North Carolina 27613, US

CHEADLE, John B.

Durham North Carolina 27705, US

ILAGAN, Roger Marquez

Durham North Carolina 27705, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.